ACME Research Solutions, an India-based in vitro research and formulation laboratory, has expanded its support for Philippine ...

In recent decades, rapid progression of monoclonal antibody (mAb) development has culminated in approvals for more than one hundred therapeutics in the United States. mAbs enhance the immune response ...

Data on the poly (ADP-ribose) glycohydrolase (PARG) inhibitor SYX-3759, being investigated for the treatment of homologous recombination deficient (HRD) malignancies, were recently discussed by ...

Medical device manufacturers use cytotoxicity testing to help prove that devices that come into contact with the human body are biocompatible. Testing results are critical for gaining market access, ...

In spite of the recent advancements in oncology, the overall survival rate for pancreatic cancer has not improved over the last five decades. Eucalypts have been linked with cytotoxic and anticancer ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates ...

Telomir Pharmaceuticals (TELO) announced new in vitro findings showing that its investigational compound Telomir-1 kills aggressive human leukemia ...

Immunosenescence , the natural decline of the immune system with age, significantly reduces the effectiveness of cancer ...

The open-label, multicenter, first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of RNDO-564 both as a monotherapy and in combination ...